Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Total Liabilities: 2018-2024

Historic Total Liabilities for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to $629.6 million.

  • Legend Biotech's Total Liabilities rose 13.23% to $701.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 8.61%. This contributed to the annual value of $629.6 million for FY2024, which is 5.42% up from last year.
  • As of FY2024, Legend Biotech's Total Liabilities stood at $629.6 million, which was up 5.42% from $597.2 million recorded in FY2023.
  • In the past 5 years, Legend Biotech's Total Liabilities ranged from a high of $629.6 million in FY2024 and a low of $124.3 million during FY2020.
  • In the last 3 years, Legend Biotech's Total Liabilities had a median value of $597.2 million in 2023 and averaged $604.5 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first crashed by 69.72% in 2020, then surged by 184.36% in 2021.
  • Yearly analysis of 5 years shows Legend Biotech's Total Liabilities stood at $124.3 million in 2020, then spiked by 184.36% to $353.5 million in 2021, then spiked by 65.95% to $586.7 million in 2022, then grew by 1.80% to $597.2 million in 2023, then rose by 5.42% to $629.6 million in 2024.